Product and service applications across air health, sleep health, foot health, head and personal care — and Datasea’s first-generation acoustic-medical product platform.
Datasea’s acoustic-healthcare activities include product and service applications in air health, sleep health, foot health, head and personal care. These applications combine acoustic technologies with sensing, device control and software-enabled service capabilities, with product-specific configurations for different use scenarios.
Acoustic air-care products combining ultrasound, sensing and device control.
Acoustic sleep-aid products with sound delivery and software services.
Sound waves remove bacteria and odors to create a healthy, hygienic and high quality living environment
Head and personal-care applications with product-specific configurations.
NeuroVibe is Datasea’s first-generation acoustic-medical product platform developed around acoustic intelligence, non-invasive biofeedback and brain-computer-interface technologies. Depending on the model and configuration, NeuroVibe may integrate physiological or EEG-related signal acquisition, acoustic or vibroacoustic stimulation, signal processing, AI-assisted analysis, feedback functions and personalized parameter adjustment.
Following the end of FY2026, the relevant operating entity completed U.S. FDA establishment registration and device listing for the NeuroVibe NV-02 and NV-03 models. Based on currently available FDA registration information, the listed devices are associated with product code HCC, are classified as Class II devices and fall under 21 CFR 882.5050, “Biofeedback Device.”
FDA establishment registration, device listing and a 510(k)-exempt classification do not constitute FDA approval, clearance, certification or endorsement and do not establish effectiveness for any particular disease or therapeutic use. Marketing, labeling, distribution and use in the United States remain subject to applicable FDA requirements.